BCRX Stock Soars After Filing Treatment for Japanese Approval
BCRX stock is soaring today after BioCryst Pharmaceuticals (NASDAQ:BCRX) announced that it had filed for regulatory approval in Japan for Berotralstat, a prophylactic treatment of hereditary angioedema (HAE). BioCryst has already received Orphan Drug and ... [Read]